# Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/captopril-sq-14-225-d-3-mercapto-2-methylpropanoyl-l-proline-a-novel-orally/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bernard Rubin,Michael J. Antonaccio,Zola P. Horovitz |
| Citations | 116 |
| DOI | 10.1016/0033-0620(78)90024-5 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Nursing |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2071150276 |
| PMID | 214818 |
| Type | article |
| Year | 1978 |

## Paper authors

- [Bernard Rubin](https://scholariq.org/researchers/bernard-rubin/)

## Paper primary topic

- [Protein Hydrolysis and Bioactive Peptides](https://scholariq.org/topics/protein-hydrolysis-and-bioactive-peptides/)

## Paper topics

- [Protein Hydrolysis and Bioactive Peptides](https://scholariq.org/topics/protein-hydrolysis-and-bioactive-peptides/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Vitamin K Research Studies](https://scholariq.org/topics/vitamin-k-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.